Home › Therapeutic areas › Renal › Focal Segmental Glomerulosclerosis
Focal Segmental Glomerulosclerosis (4 companies)
Companies with an active program in Focal Segmental Glomerulosclerosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | HematologyOphthalmologyRenalRespiratory Rare | 1 | Approved | 14 |
| PCSA | Processa Pharmaceuticals, Inc. | GI/HepatologyOncologyRenal Rare | 1 | Phase 2 | 8 |
| TVTX | Travere Therapeutics, Inc. | MetabolicRenal Rare | 1 | Approved | 4 |
| VERA | Vera Therapeutics, Inc. | Infectious DiseaseRenal Rare | 1 | NDA Submitted | 8 |
No companies match.